Product image of Eribulin Advanz Pharma (Eribulin Mesylate) supplied by GNH India

Eribulin Advanz Pharma

Active Ingredient:
Eribulin Mesylate
Origin:
EU

Eribulin Advanz Pharma (Eribulin Mesylate)

Eribulin Mesylate is a chemotherapy medication used to treat certain types of cancer. It works by slowing or stopping cancer cell growth. Learn more about Eribulin Mesylate uses and effects.

Manufacturer / TM Owner

Advanz Pharma Limited

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

  • Eribulin Mesylate is primarily used in the treatment of metastatic breast cancer. It is administered intravenously and is designed to target and destroy cancer cells. This medication is often considered when other treatments have not been effective. Eribulin Mesylate is part of a class of drugs known as microtubule dynamics inhibitors, which interfere with the cell division process.

Side Effects

  • Common effects of Eribulin Mesylate may include fatigue, nausea, and hair loss. Some individuals may also experience peripheral neuropathy, which can cause numbness or tingling in the hands and feet. It is important to discuss any persistent or severe side effects with a healthcare provider.

Precautions & Warnings

  • Eribulin Mesylate should be handled with care and administered by a healthcare professional. It is important to follow all safety guidelines when using this medication. Patients should be monitored regularly for any signs of adverse reactions. Pregnant women or those planning to become pregnant should consult a healthcare provider before using Eribulin Mesylate.

Avoid Interactions

  • Eribulin Mesylate may interact with other medications, including those that affect the liver or bone marrow. It is important to inform your healthcare provider about all medications you are taking to avoid potential interactions. Alcohol and certain foods may also affect how this medication works.

Frequently Asked Questions

Eribulin Mesylate is used to treat metastatic breast cancer, particularly when other treatments have not been effective.

Eribulin Mesylate is administered intravenously by a healthcare professional.

Common side effects include fatigue, nausea, hair loss, and peripheral neuropathy.

Pregnant women or those planning to become pregnant should consult a healthcare provider before using Eribulin Mesylate.

If you experience severe or persistent side effects, it is important to contact your healthcare provider immediately.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Eribulin Mesylate

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT